State Street Corp Nu Cana PLC Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.59 - $1.06 $41,338 - $74,268	-70,065 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.74 - $3.27 $2,306 - $10,192	3,117 Added 4.66%	70,065 $70,000
Q4 2021 Feb 14, 2022	BUY	$2.02 - $2.9 $2,492 - $3,578	1,234 Added 1.88%	66,948 $159,000
Q3 2021 Nov 15, 2021	BUY	$1.95 - $2.85 $128,142 - $187,284	65,714 New	65,714 $170,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $65.8M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.